FDA warns Glenmark for failure to investigate dissolution failures
Regulatory NewsJoanne S. Eglovitch
Audit/inspectionCDERComplianceGMPManufacturingPharmaceuticalsQuality Assurance and ControlRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)Warning letters